| abstract |
One or more human chorionic gonadotropin β subunit (hCG-β), human placental lactogen (hPL), human corticotropin releasing hormone (hCRH), KiSS-1 metastasis inhibition in maternal blood Quantitative measurement of mRNA species encoding gene (KISS1), tissue factor pathway inhibitor 2 (TPFI2), placenta-specific gene 1 (PLAC1) or glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and mRNA species Compared to the standard control, methods and kits are provided for monitoring, diagnosing or predicting preeclampsia, fetal chromosomal abnormalities, and early labor in pregnant women as well as detecting pregnancy in women. |